Fractyl Health (GUTS) Retained Earnings (2023 - 2026)
Fractyl Health (GUTS) reported Retained Earnings of -$547.0 million for Q1 2026, down 24.61% year-on-year from -$725.6 million in Q1 2025, and up 1.66% quarter-over-quarter from -$556.3 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Retained Earnings data on file, last reported at -$547.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 24.61% year-over-year to -$547.0 million; the trailing twelve-month figure through Mar 2026 stood at -$547.0 million (down 24.61% YoY), and the FY2025 full-year result was -$556.3 million, down 33.94% from the prior year.
- Retained Earnings for Q1 2026 stood at -$547.0 million, up from -$556.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$346.6 million in Q4 2023 and bottomed at -$556.3 million in Q4 2025.
- A 4-year average of -$439.1 million and a median of -$427.2 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings retreated 19.82% in 2024 and slumped 33.94% in 2025, its largest moves.
- Tracing GUTS's Retained Earnings over 4 years: stood at -$346.6 million in 2023, then retreated by 19.82% to -$415.3 million in 2024, then slumped by 33.94% to -$556.3 million in 2025, then gained by 1.66% to -$547.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$547.0 million, -$556.3 million, and -$512.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | -547.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -547.05 Mn |
| Dec 31, 2025 | -556.26 Mn |
| Sep 30, 2025 | -512.54 Mn |
| Jun 30, 2025 | -466.93 Mn |
| Mar 31, 2025 | -439.00 Mn |
| Dec 31, 2024 | -415.31 Mn |
| Sep 30, 2024 | -390.34 Mn |
| Jun 30, 2024 | -367.17 Mn |
| Mar 31, 2024 | -349.94 Mn |
| Dec 31, 2023 | -346.62 Mn |